Latest Insider Transactions at Bluebird Bio, Inc. (BLUE)
This section provides a real-time view of insider transactions for Bluebird Bio, Inc. (BLUE). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of bluebird bio, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of bluebird bio, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 01
2023
|
Andrew Obenshain President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,420
-0.59%
|
$8,520
$6.38 P/Share
|
|
Feb 01
2023
|
Richard A Colvin Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,153
-1.55%
|
$6,918
$6.38 P/Share
|
|
Feb 01
2023
|
Thomas J Klima |
SELL
Payment of exercise price or tax liability
|
Direct |
2,260
-2.68%
|
$13,560
$6.38 P/Share
|
|
Jan 11
2023
|
Nick Leschly |
SELL
Open market or private sale
|
Direct |
4,290
-1.51%
|
$30,030
$7.8 P/Share
|
|
Jan 11
2023
|
Richard A Colvin Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
557
-0.74%
|
$3,899
$7.8 P/Share
|
|
Jan 11
2023
|
Andrew Obenshain President and CEO |
SELL
Open market or private sale
|
Direct |
3,178
-1.29%
|
$22,246
$7.8 P/Share
|
|
Dec 01
2022
|
Christopher Krawtschuk Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+50.0%
|
-
|
|
Nov 04
2022
|
Andrew Obenshain President and CEO |
SELL
Open market or private sale
|
Direct |
1,263
-0.51%
|
$7,578
$6.41 P/Share
|
|
Nov 04
2022
|
Richard A Colvin Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
218
-0.29%
|
$1,308
$6.41 P/Share
|
|
Nov 01
2022
|
Richard A Colvin Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
30,000
+28.57%
|
-
|
|
Oct 17
2022
|
Elisabeth Leiderman |
SELL
Open market or private sale
|
Direct |
1,004
-8.05%
|
$6,024
$6.46 P/Share
|
|
Sep 01
2022
|
Thomas J Klima |
BUY
Grant, award, or other acquisition
|
Direct |
11,000
+11.77%
|
-
|
|
Aug 19
2022
|
Jason Cole Chief Strategy & Financial Off |
SELL
Open market or private sale
|
Direct |
14,194
-6.97%
|
$70,970
$5.53 P/Share
|
|
Aug 04
2022
|
Andrew Obenshain President and CEO |
SELL
Open market or private sale
|
Direct |
21,805
-8.11%
|
$87,220
$4.39 P/Share
|
|
Aug 04
2022
|
Jason Cole Chief Strategy & Financial Off |
SELL
Open market or private sale
|
Direct |
7,448
-3.53%
|
$29,792
$4.39 P/Share
|
|
Jul 12
2022
|
Anne Virginie Eggimann Chief Regulatory Officer |
SELL
Open market or private sale
|
Direct |
1,358
-3.11%
|
$5,432
$4.95 P/Share
|
|
Jun 22
2022
|
Najoh Tita Reid |
BUY
Grant, award, or other acquisition
|
Direct |
3,109
+19.96%
|
-
|
|
Jun 22
2022
|
Elisabeth Leiderman |
BUY
Grant, award, or other acquisition
|
Direct |
3,109
+19.96%
|
-
|
|
Jun 22
2022
|
John O Agwunobi |
BUY
Grant, award, or other acquisition
|
Direct |
3,109
+16.55%
|
-
|
|
Jun 22
2022
|
Mark Vachon |
BUY
Grant, award, or other acquisition
|
Direct |
4,353
+23.4%
|
-
|
|
Jun 22
2022
|
Nick Leschly |
BUY
Grant, award, or other acquisition
|
Direct |
3,109
+1.08%
|
-
|
|
Jun 22
2022
|
Charlotte Jones Burton |
BUY
Grant, award, or other acquisition
|
Direct |
3,109
+28.57%
|
-
|
|
Jun 03
2022
|
Thomas J Klima |
SELL
Open market or private sale
|
Direct |
3,753
-4.99%
|
$11,259
$3.07 P/Share
|
|
Mar 07
2022
|
Charlotte Jones Burton |
BUY
Grant, award, or other acquisition
|
Direct |
4,663
+50.0%
|
-
|
|
Feb 01
2022
|
Jason Cole Chief Strategy & Financial Off |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+10.58%
|
-
|
|
Feb 01
2022
|
Thomas J Klima |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+24.95%
|
-
|
|
Feb 01
2022
|
Gina Consylman Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+16.62%
|
-
|
|
Feb 01
2022
|
Jessica Whitten Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,500
+11.64%
|
-
|
|
Feb 01
2022
|
Anne Virginie Eggimann Chief Regulatory Officer |
BUY
Grant, award, or other acquisition
|
Direct |
17,000
+28.05%
|
-
|
|
Feb 01
2022
|
Andrew Obenshain President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
18,000
+6.27%
|
-
|
|
Jan 11
2022
|
Andrew Obenshain President and CEO |
SELL
Open market or private sale
|
Direct |
4,683
-1.86%
|
$42,147
$9.64 P/Share
|
|
Jan 11
2022
|
Nick Leschly |
SELL
Open market or private sale
|
Direct |
5,068
-1.77%
|
$45,612
$9.64 P/Share
|
|
Jan 11
2022
|
Jason Cole Chief Strategy & Financial Off |
SELL
Open market or private sale
|
Direct |
3,387
-1.79%
|
$30,483
$9.64 P/Share
|
|
Jan 11
2022
|
Jessica Whitten Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
279
-0.56%
|
$2,511
$9.64 P/Share
|
|
Jan 10
2022
|
Andrew Obenshain President and CEO |
SELL
Open market or private sale
|
Direct |
3,042
-0.6%
|
$27,378
$9.32 P/Share
|
|
Jan 10
2022
|
Nick Leschly |
SELL
Open market or private sale
|
Direct |
2,369
-0.82%
|
$21,321
$9.4 P/Share
|
|
Jan 10
2022
|
Jason Cole Chief Strategy & Financial Off |
SELL
Open market or private sale
|
Direct |
1,584
-0.83%
|
$14,256
$9.4 P/Share
|
|
Jan 10
2022
|
Jessica Whitten Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
130
-0.26%
|
$1,170
$9.4 P/Share
|
|
Jan 05
2022
|
Jessica Whitten Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
2,984
-5.65%
|
$29,840
$10.44 P/Share
|
|
Dec 22
2021
|
Jessica Whitten Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,502
+15.25%
|
-
|
|
Dec 07
2021
|
Andrew Obenshain President and CEO |
SELL
Open market or private sale
|
Direct |
832
-0.33%
|
$8,320
$10.18 P/Share
|
|
Nov 11
2021
|
Denice Torres Director |
BUY
Other acquisition or disposition
|
Direct |
1,476
+17.56%
|
-
|
|
Nov 11
2021
|
Andrew Obenshain President and CEO |
BUY
Other acquisition or disposition
|
Direct |
245,371
+23.02%
|
-
|
|
Nov 11
2021
|
William D Baird Iii Chief Financial Officer |
BUY
Other acquisition or disposition
|
Direct |
14,768
+11.37%
|
-
|
|
Nov 11
2021
|
Sarah Js Glickman Director |
BUY
Other acquisition or disposition
|
Direct |
0
|
-
|
|
Nov 11
2021
|
Ramy Ibrahim Director |
BUY
Other acquisition or disposition
|
Direct |
0
|
-
|
|
Nov 11
2021
|
Nick Leschly |
BUY
Other acquisition or disposition
|
Direct |
43,688
+2.14%
|
-
|
|
Nov 11
2021
|
Daniel Lynch Director |
BUY
Other acquisition or disposition
|
Direct |
0
|
-
|
|
Nov 11
2021
|
Wendy L Dixon Director |
BUY
Other acquisition or disposition
|
Direct |
6,241
+34.41%
|
-
|
|
Nov 11
2021
|
Marcela V. Maus Director |
BUY
Other acquisition or disposition
|
Direct |
0
|
-
|